Literature DB >> 10872173

Transient oedema of the cervical spinal cord.

S Sartoretti-Schefer1, S Kollias, A Valavanis.   

Abstract

Transient but very intense oedema of the cervical spinal cord was observed in two patients with obstruction of the cerebrospinal fluid (CSF) pathways. Both presented with hydrocephalus, one due to an infratentorial obstructing mass and the other due to postmeningitic adhesive obstruction of the outlet foramina of the fourth ventricle. In animal experiments with obstruction of CSF pathways (due to outlet foramina obstruction or to downward tentorial herniation) flattening and stretching of the ependymal cells along the central canal is observed, followed by disruption and splitting of the ependymal lining and then by extracellular oedema of the subependymal tissue. Without treatment, frank cavity formation develops in a fourth stage. In our two patients, however, most probably because of appropriate decompressive therapy, the oedema disappeared completely without a residual spinal cord lesion.

Entities:  

Mesh:

Year:  2000        PMID: 10872173     DOI: 10.1007/s002340050886

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  3 in total

1.  Syringomyelia with quadriparesis in CSF shunt malfunction: a case illustration.

Authors:  Juan F Martínez-Lage; Fernando Alarcón; Antonio López López-Guerrero; Matías Felipe-Murcia; Antonio Ruíz-Espejo Vilar; María-José Almagro
Journal:  Childs Nerv Syst       Date:  2010-05-06       Impact factor: 1.475

2.  Transient edema of the spinal cord as a result of spontaneous acute epidural hematoma in the thoracic spine.

Authors:  C M Gonzalez; G Matheus; S Solander; M Castillo
Journal:  Emerg Radiol       Date:  2004-07-14

Review 3.  Endoscopic Treatment Strategy for a Disproportionately Large Communicating Fourth Ventricle: Case Series and Literature Review.

Authors:  Teppei Kawabata; Kazuhito Takeuchi; Yuichi Nagata; Takayuki Ishikawa; Jungsu Choo; Toshihiko Wakabayashi
Journal:  Neurol Med Chir (Tokyo)       Date:  2020-06-12       Impact factor: 1.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.